We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Adhesive Biosensor Transmits Core Health Biometrics

By HospiMedica International staff writers
Posted on 29 Sep 2014
A new home monitoring device brings clinical-grade office care into patient homes, notifying doctors when physiological data falls outside selected parameters.

The HealthPatch MD is a Band-Aid-like biosensor that can relay real-time health indicators from patients that are recovering from surgery or medical treatments, are receiving long-term care for a chronic condition like heart disease, diabetes, cancer, or those who are experiencing symptoms that cannot be easily diagnosed in a single office visit. More...
The sensor’s technologies enable the device to provide single-lead electrocardiogram (ECG), heart rate and variability, respiratory rate, skin temperature, posture (including fall detection and severity), and number of steps.

On-board proprietary SensorFusion algorithms are used to process thousands of data points per minute to produce accurate robust measurements, which are transmitted through the cloud to a doctor’s smartphone or tablet for analysis. The device has two components; a reusable sensor module and a disposable adhesive patch, which goes onto the skin using one of three adhesives (silicone or a hydrocolloid), depending on the activity level; battery life is between 48 and 72 hours, and the patch is water resistant.

The device weighs only 10 grams and is only 6 mm thick, a form factor that is comfortable for patients and less obtrusive than conventional monitoring equipment. The data reporting may be customized by a healthcare professional to meet individual needs. The sensor uses Bluetooth 4.0 to connect to a smartphone or to a relay that transfers the information by Wi-Fi to the cloud, meeting cyber security guidelines. HealthPatch MD is a product of Vital Connect (Campbell, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“Bulky machines that interfere with daily activities will no longer inhibit a patient’s normal routine,” said Nersi Nazari, CEO of Vital Connect. “Monitoring will occur seamlessly and will not interfere with a patient’s routine at home, work, or leisure. Patients will have confidence that their condition is being monitored by a healthcare professional outside of the healthcare setting.”

Related Links:

Vital Connect 



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.